Jeonghee Cho
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Clinical and Molecular Characterization of a Rare EGFR cis Compound L833V/H835L Mutation in Non-Small Cell Lung Cancer.
Journal: Cancer research communications
Published: December 31, 2025
Evaluation of clinical chemistry using diluted sera in mice and rats.
Journal: BMC veterinary research
Published: December 03, 2025
RAF1 extrachromosomal DNA amplification confers acquired erlotinib resistance in a non-small cell lung cancer cell model.
Journal: Signal transduction and targeted therapy
Published: November 17, 2025
Comparison of repeated toxicity of polyhexamethyleneguanidine phosphate, a causative agent of humidifier disinfectant tragedy, in young and adult mice.
Journal: Scientific reports
Published: July 31, 2024
Exposure to polyhexamethyleneguanidine phosphate in early life dampens pulmonary damage compared to adult mice.
Journal: Chemico-biological interactions
Published: March 07, 2024
Functional loss of ERBB receptor feedback inhibitor 1 (MIG6) promotes glioblastoma tumorigenesis by aberrant activation of epidermal growth factor receptor (EGFR).
Journal: Molecular oncology
Published: December 05, 2023
Characterization of immune development of fetal and early-life of minipigs.
Journal: International immunopharmacology
Published: March 02, 2023
Identification and validation of stable reference genes for quantitative real time PCR in different minipig tissues at developmental stages.
Journal: BMC genomics
Published: January 28, 2022
The Impact of EGFR Tyrosine Kinase Inhibitor on the Natural Course of Concurrent Subsolid Nodules in Patients with Non-Small Cell Lung Cancer.
Journal: Cancer research and treatment
Published: July 16, 2021
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 06, 2021
Activation of CXCL12-CXCR4 signalling induces conversion of immortalised embryonic kidney cells into cancer stem-like cells.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: November 05, 2020
Last Updated: 09/26/2026